All news

Stockholders face another vote on $0.54 warrants at Theriva Biologics (TOVX).

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Theriva Biologics is calling a Special Meeting of Stockholders on November 18, 2026, to vote on three key proposals. These include increasing the authorized common stock to 500,000,000 shares, re-approving the issuance of up to 16,184,560 common shares upon warrant exercise from a 2025 private placement, and a proposal to adjourn the meeting if needed to solicit more votes.

Read original source

TOVX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.